KR910008637B1 - 심근 미오신 중사슬에 대한 단일클론항체 - Google Patents

심근 미오신 중사슬에 대한 단일클론항체 Download PDF

Info

Publication number
KR910008637B1
KR910008637B1 KR1019840003916A KR840003916A KR910008637B1 KR 910008637 B1 KR910008637 B1 KR 910008637B1 KR 1019840003916 A KR1019840003916 A KR 1019840003916A KR 840003916 A KR840003916 A KR 840003916A KR 910008637 B1 KR910008637 B1 KR 910008637B1
Authority
KR
South Korea
Prior art keywords
heavy chain
myosin heavy
antibody
myocardial
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
KR1019840003916A
Other languages
English (en)
Korean (ko)
Other versions
KR850001282A (ko
Inventor
요시오 야자끼
마사히또 스기
Original Assignee
야마사 쇼오유 가부시끼가이샤
하마구찌 미찌오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 야마사 쇼오유 가부시끼가이샤, 하마구찌 미찌오 filed Critical 야마사 쇼오유 가부시끼가이샤
Publication of KR850001282A publication Critical patent/KR850001282A/ko
Application granted granted Critical
Publication of KR910008637B1 publication Critical patent/KR910008637B1/ko
Expired legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10Cells modified by introduction of foreign genetic material
    • C12N5/12Fused cells, e.g. hybridomas
    • C12N5/16Animal cells
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/40Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/10Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
    • A61K51/1075Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody the antibody being against an enzyme
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1019840003916A 1983-07-06 1984-07-06 심근 미오신 중사슬에 대한 단일클론항체 Expired KR910008637B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP122579 1983-07-06
JP???58-122579 1983-07-06
JP58122579A JPS6028998A (ja) 1983-07-06 1983-07-06 心筋ミオシン重鎖に対する単一クロ−ン抗体

Publications (2)

Publication Number Publication Date
KR850001282A KR850001282A (ko) 1985-03-18
KR910008637B1 true KR910008637B1 (ko) 1991-10-19

Family

ID=14839400

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019840003916A Expired KR910008637B1 (ko) 1983-07-06 1984-07-06 심근 미오신 중사슬에 대한 단일클론항체

Country Status (7)

Country Link
US (1) US4767843A (enExample)
EP (1) EP0131834B1 (enExample)
JP (1) JPS6028998A (enExample)
KR (1) KR910008637B1 (enExample)
AU (1) AU570696B2 (enExample)
CA (1) CA1225608A (enExample)
DE (1) DE3485965T2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60201260A (ja) * 1984-03-27 1985-10-11 Yamasa Shoyu Co Ltd 心疾患診断薬
JPH0625762B2 (ja) * 1985-06-13 1994-04-06 ヤマサ醤油株式会社 ミオシン軽鎖の測定法
GB2200358B (en) * 1987-01-27 1991-02-27 Univ Birmingham Materials for in vivo detection of cardiac damage, and methods for their preparation
US5046499A (en) * 1988-06-13 1991-09-10 Centocor, Inc. Method for myocardial infarct risk assessment
WO1990011520A1 (en) * 1989-03-28 1990-10-04 Yamasa Shoyu Kabushiki Kaisha Antibody against heavy chain of smooth muscle myosin
US5830720A (en) * 1989-04-21 1998-11-03 Boehringer Mannheim Gmbh Recombinant DNA and expression vector for the repressible and inducible expression of foreign genes
US5364612A (en) * 1991-05-06 1994-11-15 Immunomedics, Inc. Detection of cardiovascular lesions
EP0782863B1 (en) * 1994-10-25 2003-06-11 Yamasa Corporation Antibody reagent for detecting dissecting aortic aneurysm and use thereof
CA2246666A1 (en) * 1996-02-19 1997-08-21 Yamasa Corporation Diagnostic agent for angiopathic diseases
US6248869B1 (en) 1997-05-29 2001-06-19 Medical Analysis Systems, Inc. Troponin I forms and use of the same

Also Published As

Publication number Publication date
CA1225608A (en) 1987-08-18
AU570696B2 (en) 1988-03-24
DE3485965D1 (de) 1992-12-03
EP0131834A3 (en) 1987-06-24
JPH0231958B2 (enExample) 1990-07-17
US4767843A (en) 1988-08-30
EP0131834B1 (en) 1992-10-28
DE3485965T2 (de) 1993-03-18
JPS6028998A (ja) 1985-02-14
AU3022884A (en) 1985-01-10
KR850001282A (ko) 1985-03-18
EP0131834A2 (en) 1985-01-23

Similar Documents

Publication Publication Date Title
US4628027A (en) Vitro diagnostic methods using monoclonal antibodies against connective tissue proteins
CA1190873A (en) Recombinant monoclonal antibodies
EP0741144B1 (en) Antiannexin-v monoclonal antibody, process for producing the same, and use therof
KR910008637B1 (ko) 심근 미오신 중사슬에 대한 단일클론항체
JP3018110B2 (ja) モノクローナル抗体
NZ204255A (en) Monoclonal antibodies against connective tissue proteins:use in diagnosis and monitoring of human diseases
JP2020148557A (ja) 試料中のhmgb1の測定方法及び測定試薬
EP0205177B1 (en) Method of assaying myosin light chain
US5358850A (en) Sandwich immunoassay of β-n-acetylglucosaminidase and monoclonal antibody used therein
DK172758B1 (da) Monoklonalt antistof mod prosomale proteiner, immortaliseret cellelinie, der producerer antistoffet, fremgangsmåde til påvi
JP5058403B2 (ja) Ck−mb活性測定法およびck−mb活性測定試薬
US7148063B2 (en) Mitochondrial creatine kinase antibody
WO1986002359A1 (en) Monoclonal antibodies and their use
US4952507A (en) Production and diagnostic use of antibodies against pancreatic alpha-amaylase
AU2006213411A1 (en) Antibody for assay of ADAMTS13 activity and method of activity assay
IE881290L (en) Monoclonal antibodies for the selective immunological¹determination of intact procollagen peptide (Type III) and¹procollagen (Type III) in body fluids
JPH0320240B2 (enExample)
JP3036545B2 (ja) モノクローナル抗体とこれを産生するハイブリドーマ細胞株、およびこれを用いる免疫学的測定法
FI93469C (fi) Menetelmä hybridoomasolulinjan ja sen tuottaman vasta-aineen tuottamiseksi
JP2567664B2 (ja) ヒトMnス−パ−オキシドジスムタ−ゼに対するモノクロ−ナル抗体
WO1986002356A1 (en) Monoclonal antibodies and their use
JPH061271B2 (ja) カテコ−ルアミンの酸性代謝物に対する抗体の製造法およびそれに使用する抗原
JPS60253871A (ja) 抗アポa−1抗体
JPH0977798A (ja) 抗コレステリルエステル転送蛋白抗体
JPH0690784A (ja) モノクローナル抗体及びその利用

Legal Events

Date Code Title Description
PA0109 Patent application

St.27 status event code: A-0-1-A10-A12-nap-PA0109

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

G160 Decision to publish patent application
PG1605 Publication of application before grant of patent

St.27 status event code: A-2-2-Q10-Q13-nap-PG1605

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U11-oth-PR1002

Fee payment year number: 1

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 7

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 8

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 9

FPAY Annual fee payment

Payment date: 20001011

Year of fee payment: 10

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 10

LAPS Lapse due to unpaid annual fee
PC1903 Unpaid annual fee

St.27 status event code: A-4-4-U10-U13-oth-PC1903

Not in force date: 20011020

Payment event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

PC1903 Unpaid annual fee

St.27 status event code: N-4-6-H10-H13-oth-PC1903

Ip right cessation event data comment text: Termination Category : DEFAULT_OF_REGISTRATION_FEE

Not in force date: 20011020